Clinical Trial Update: Bone Marrow Derived Mononuclear Cells for Ischemic Cardiomyopathy [NA]

View source ↗

Summary

A clinical trial evaluating bone marrow derived mononuclear cells for ischemic cardiomyopathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: Kai Jaquet, PhD, DSc | Conditions: Heart Disease | NA | Status: TERMINATED